Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish Cohort
Background/Aims. Obesity is a well-established risk factor for the development of numerous chronic diseases. However, there is a small proportion of obese individuals that seem to escape these aforementioned conditions—Metabolically Healthy Obesity (MHO). Our aim was to do a metabolic and biomarker...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Journal of Obesity |
| Online Access: | http://dx.doi.org/10.1155/2021/6616983 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832560614638092288 |
|---|---|
| author | J. Korduner P. M. Nilsson O. Melander M. J. Gerl G. Engström E. Bachus M. Magnusson F. Ottosson |
| author_facet | J. Korduner P. M. Nilsson O. Melander M. J. Gerl G. Engström E. Bachus M. Magnusson F. Ottosson |
| author_sort | J. Korduner |
| collection | DOAJ |
| description | Background/Aims. Obesity is a well-established risk factor for the development of numerous chronic diseases. However, there is a small proportion of obese individuals that seem to escape these aforementioned conditions—Metabolically Healthy Obesity (MHO). Our aim was to do a metabolic and biomarker profiling of MHO individuals. Method. Associations between different biomarkers (proteomics, lipidomics, and metabolomics) coupled to either MHO or metabolically unhealthy obese (MUO) individuals were analyzed through principal component analysis (PCA). Subjects were identified from a subsample of 416 obese individuals, selected from the Malmö Diet and Cancer study—Cardiovascular arm (MDCS-CV, n = 3,443). They were further divided into MHO (n = 143) and MUO (n = 273) defined by a history of hospitalization, or not, at baseline inclusion, and nonobese subjects (NOC, n = 3,027). Two distinctive principle components (PL2, PP5) were discovered with a significant difference and thus further investigated through their main loadings. Results. MHO individuals had a more metabolically favorable lipid and glucose profile than MUO subjects, that is, lower levels of traditional blood glucose and triglycerides, as well as a trend of lower metabolically unfavorable lipid biomarkers. PL2 (lipidomics, p=0.02) showed stronger associations of triacylglycerides with MUO, whereas phospholipids correlated with MHO. PP5 (proteomics, p=0.01) included interleukin-1 receptor antagonist (IL-1ra) and leptin with positive relations to MUO and galanin that correlated positively to MHO. The group differences in metabolite profiles were to a large extent explained by factors included in the metabolic syndrome. Conclusion. Compared to MUO individuals, corresponding MHO individuals present with a more favorable lipid metabolic profile, accompanied by a downregulation of potentially harmful proteomic biomarkers. This unique and extensive biomarker profiling presents novel data on potentially differentiating traits between these two obese phenotypes. |
| format | Article |
| id | doaj-art-abd21020c49849d6baa0b047c2282aba |
| institution | Kabale University |
| issn | 2090-0708 2090-0716 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Obesity |
| spelling | doaj-art-abd21020c49849d6baa0b047c2282aba2025-02-03T01:27:05ZengWileyJournal of Obesity2090-07082090-07162021-01-01202110.1155/2021/66169836616983Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish CohortJ. Korduner0P. M. Nilsson1O. Melander2M. J. Gerl3G. Engström4E. Bachus5M. Magnusson6F. Ottosson7Department of Clinical Sciences, Lund University, Malmö, SwedenDepartment of Clinical Sciences, Lund University, Malmö, SwedenDepartment of Clinical Sciences, Lund University, Malmö, SwedenLipotype GmbH, Dresden, GermanyDepartment of Clinical Sciences, Lund University, Malmö, SwedenDepartment of Clinical Sciences, Lund University, Malmö, SwedenDepartment of Clinical Sciences, Lund University, Malmö, SwedenDepartment of Clinical Sciences, Lund University, Malmö, SwedenBackground/Aims. Obesity is a well-established risk factor for the development of numerous chronic diseases. However, there is a small proportion of obese individuals that seem to escape these aforementioned conditions—Metabolically Healthy Obesity (MHO). Our aim was to do a metabolic and biomarker profiling of MHO individuals. Method. Associations between different biomarkers (proteomics, lipidomics, and metabolomics) coupled to either MHO or metabolically unhealthy obese (MUO) individuals were analyzed through principal component analysis (PCA). Subjects were identified from a subsample of 416 obese individuals, selected from the Malmö Diet and Cancer study—Cardiovascular arm (MDCS-CV, n = 3,443). They were further divided into MHO (n = 143) and MUO (n = 273) defined by a history of hospitalization, or not, at baseline inclusion, and nonobese subjects (NOC, n = 3,027). Two distinctive principle components (PL2, PP5) were discovered with a significant difference and thus further investigated through their main loadings. Results. MHO individuals had a more metabolically favorable lipid and glucose profile than MUO subjects, that is, lower levels of traditional blood glucose and triglycerides, as well as a trend of lower metabolically unfavorable lipid biomarkers. PL2 (lipidomics, p=0.02) showed stronger associations of triacylglycerides with MUO, whereas phospholipids correlated with MHO. PP5 (proteomics, p=0.01) included interleukin-1 receptor antagonist (IL-1ra) and leptin with positive relations to MUO and galanin that correlated positively to MHO. The group differences in metabolite profiles were to a large extent explained by factors included in the metabolic syndrome. Conclusion. Compared to MUO individuals, corresponding MHO individuals present with a more favorable lipid metabolic profile, accompanied by a downregulation of potentially harmful proteomic biomarkers. This unique and extensive biomarker profiling presents novel data on potentially differentiating traits between these two obese phenotypes.http://dx.doi.org/10.1155/2021/6616983 |
| spellingShingle | J. Korduner P. M. Nilsson O. Melander M. J. Gerl G. Engström E. Bachus M. Magnusson F. Ottosson Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish Cohort Journal of Obesity |
| title | Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish Cohort |
| title_full | Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish Cohort |
| title_fullStr | Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish Cohort |
| title_full_unstemmed | Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish Cohort |
| title_short | Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish Cohort |
| title_sort | proteomic and metabolomic characterization of metabolically healthy obesity a descriptive study from a swedish cohort |
| url | http://dx.doi.org/10.1155/2021/6616983 |
| work_keys_str_mv | AT jkorduner proteomicandmetabolomiccharacterizationofmetabolicallyhealthyobesityadescriptivestudyfromaswedishcohort AT pmnilsson proteomicandmetabolomiccharacterizationofmetabolicallyhealthyobesityadescriptivestudyfromaswedishcohort AT omelander proteomicandmetabolomiccharacterizationofmetabolicallyhealthyobesityadescriptivestudyfromaswedishcohort AT mjgerl proteomicandmetabolomiccharacterizationofmetabolicallyhealthyobesityadescriptivestudyfromaswedishcohort AT gengstrom proteomicandmetabolomiccharacterizationofmetabolicallyhealthyobesityadescriptivestudyfromaswedishcohort AT ebachus proteomicandmetabolomiccharacterizationofmetabolicallyhealthyobesityadescriptivestudyfromaswedishcohort AT mmagnusson proteomicandmetabolomiccharacterizationofmetabolicallyhealthyobesityadescriptivestudyfromaswedishcohort AT fottosson proteomicandmetabolomiccharacterizationofmetabolicallyhealthyobesityadescriptivestudyfromaswedishcohort |